Erasca Plans to Use $550M Offering Proceeds for Drug Development
Erasca Plans to Use $550M Offering Proceeds for Drug Development Stock Titan
Erasca Plans to Use $550M Offering Proceeds for Drug Development Stock Titan
Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.